With revenues declining and net losses increasing, Seattle-based Adaptive Biotechnologies on Thursday said it hired Goldman Sachs to help conduct a review of strategic alternatives for its Minimal Residual Disease… Read More
— Seattle-area cybersecurity company Cyemptive named Ray McCay as its new chief revenue officer. McCay spent 25 years at Hitachi Data Systems, serving as SVP of global product strategy for… Read More
A Star Wars theme complemented the rising stars on hand as light sabers glowed and a galaxy of lights twinkled overhead during the GeekWire Awards on Thursday in Seattle. We… Read More
The five finalists for Workplace of the Year at the GeekWire Awards rely on a number of policies to help employees get the most out of their work experience, from… Read More
— The Allen Institute appointed Chris Beaudoin as its new chief operations officer. Beaudoin was previously chief operating officer at Swedish, a Seattle-area healthcare system affiliated with Providence. Prior to… Read More
Adaptive Biotechnologies will raise up to $250 million in a deal announced Monday with healthcare investment firm OrbiMed, which will receive a cut of Adaptive’s revenue as part of the… Read More
Adaptive Biotechnologies unveiled a new type of test Wednesday for Lyme disease that may be most useful at detecting disease during the early stages of infection. Conventional tests for the… Read More
— Lance Baldo stepped down as chief medical officer of Adaptive Biotechnologies. Baldo is “moving on to pursue another professional opportunity in the early cancer screening market close to home,”… Read More
As a bear market takes a bite out of biotech stock values that had soared during the pandemic, some companies are retrenching. Adaptive Biotechnologies had recently doubled its headcount as… Read More
— Adaptive Biotechnologies has a new CFO. Tycho Peterson comes from J.P. Morgan Chase, where he most recently served in its healthcare group as managing director, life science tools and… Read More
Adaptive Biotechnologies is laying off 12% of its workforce, or about 100 employees, GeekWire has learned. “We have made the hard decision to streamline our workforce,” a spokesperson told… Read More
Adaptive Biotechnologies, which develops technology to assess the immune response, posted $154.3 million in revenue last year, a 57% year-over-year increase. The number was revealed in the Seattle-based company’s fourth… Read More
— Chad Cohen will step down as CFO of Adaptive Biotechnologies on Feb. 15. Prior to joining Adaptive in 2015, Cohen was CFO of Zillow Group. Principal accounting officer Kyle… Read More
— Future For Us co-founder and former CEO Sage Ke’alohilani Quiamno is now a diversity, equity and inclusion business partner for Amazon Prime Video and Studios. “I was drawn to… Read More
After doubling its workforce during the pandemic, Adaptive Biotechnologies finally has room to grow. The company on Tuesday will cut the ribbon on its new 100,086 square-foot headquarters in Seattle’s… Read More
— Seattle-based Adaptive Biotechnologies announced Nitin Sood as its first-ever chief commercial officer. Sood will report to Adaptive Biotech CEO Chad Robins. Based in the San Francisco Bay Area, Sood… Read More
The greater Seattle area is a hotbed for health technology and the past year has seen groundbreaking advancements in the sector. So it’s little wonder that there’s stiff competition for… Read More
— Adaptive Biotechnologies co-founders and brothers Chad and Harlan Robins are among the directors of a new life sciences SPAC. The blank check company is called CM Life Sciences III… Read More
— Sea.citi, an organization that works to connect tech sector employees with civic life, announced three new board members: Zillow Government Relations and Public Affairs Manager Anna Boone. Janice Dearlove,… Read More
On a cold, clear weekday morning last month, my quest to figure out whether I had COVID-19 in the early days of the pandemic took me to my back porch,… Read More
Seattle-based Adaptive Biotechnologies, which develops technology to sequence the human immune system to diagnose and treat disease, posted revenue of $30.2 million for the fourth quarter, up 25% from a… Read More
Adaptive Biotechnologies says it’s proceeding with plans to launch a new type of test to determine if someone was previously infected with SARS-CoV-2, the virus that causes COVID-19, after a… Read More
Adaptive Biotechnologies beat expectations for its fiscal third quarter as the Seattle company continues to use its immune medicine platform in the fight against COVID-19. Adaptive posted revenue of $26.3… Read More
— Amazon hired Anne Toth as director of Alexa Trust, a team focused on the privacy, security, accessibility, ethics and biases of Amazon’s voice platform. Toth was previously VP of… Read More
Adaptive Biotechnologies’ revenue fell 5% to $21 million in the second quarter, and its net loss more than doubled to $33.5 million, due in part to reduced usage of its… Read More
Topping-off ceremonies, in which workers place the last piece of structural steel for new building, have become run-of-the-mill over the past decade in Seattle’s South Lake Union neighborhood. But the… Read More
Adaptive Biotechnologies announced Tuesday that it will sell 8 million shares of its common stock — 6 million of its own, and 2 million from an investor — to help… Read More
Seattle-based Adaptive Biotechnologies and Microsoft have launched an open-access database called ImmuneCODE to catalog the many ways in which our immune systems fight off a coronavirus infection. The project leverages… Read More
In the realm of diagnostic tests for COVID-19, there are two main approaches: PCR tests, which detect the presence of the live virus; and serology tests, which detect antibodies that… Read More
Adaptive Biotechnologies, which is working with Microsoft and Amgen to fight COVID-19 using its technology for sequencing the human immune system, reported a 65% increase in first quarter revenue, to… Read More